Erratum
for
Worden et al., J Clin Oncol 23 (1) 105-112.
Journal of Clinical Oncology, Vol 24, No 25 (September 1), 2006: pp. 4223
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.07.005
ERRATUM
The January 1, 2005, article by Worden et al, titled "Randomized Phase II Evaluation of 6 g/m2 of Ifosfamide Plus Doxorubicin and Granulocyte Colony-Stimulating Factor (G-CSF) Compared With 12 g/m2 of Ifosfamide Plus Doxorubicin and G-CSF in the Treatment of Poor-Prognosis Soft Tissue Sarcoma" (J Clin Oncol 23:105-112, 2005) contained an error.
In the Patients and Methods Section, the third sentence of the Treatment Plan Subsection was given as:
"Hydration with 5% dextrose with 120 mEq/L of sodium acetate, 500 mg/L of magnesium sulfate, 4 mEq/L of potassium chloride, and 40 mEq/L of potassium acetate was initiated at 500 mL/h 1 hour before ifosfamide administration."
Whereas it should have read:
"Hydration with 5% dextrose with 120 mEq/L of sodium acetate, 500 mg/L of magnesium sulfate, and 40 mEq/L of potassium acetate was initated at 500 mL/h 1 hour before ifosfamide administration."
The online version has been corrected in departure from the print.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
|